Researcher
Marc Peeters
- Research Expertise (University of Antwerp):My expertise is in the field of oncology or cancer research. It is mainly focused on clinical translational research. This domain is very broad and ranges from bio-research to clinical studies
- Keywords (University of Antwerp):ONCOLOGY, Medicine
- Disciplines (Ghent University):Endocrinology and metabolic diseases, Paediatrics and neonatology, Nursing
- Disciplines (University of Antwerp):Cancer therapy, Cancer biology, Cancer diagnosis, Cancer epidemiology, Cancer prevention
- Research techniques (University of Antwerp):Making protocols for studies. (Statistical) analysis of results
- Users of research expertise (University of Antwerp):Other researchers in the field. Students Pharma and Biotech companies
- See also: Marc Peeters (Ghent University)
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From1 Jan 2019 → Today - Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Responsible
From1 Oct 2009 → 31 Dec 2018 - Department of Internal medicine (Department)
Member
From1 Oct 2000 → 30 Sep 2018
Projects
1 - 10 of 67
- Dawn of a new era in drug discovery: the symphony of AI-guided small molecule design with 3D patient-derived tumor organoids.From1 Jan 2024 → TodayFunding: IOF - technology concept exploration
- Trapped ion mobility quadrupole time of flight mass spectrometer hyphenated to automated high throughput liquid chromatography.From30 Jun 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Neuroendocrine neoplasms from bench to bedside: unravelling personalised strategies through the integration of clinical data and patientderived organoids.From1 Mar 2023 → 29 Feb 2024Funding: Nonprofit institution or equivalents
- Detection and quantification of a panel of clinically relevant DNA biomarker sequences containing KRAS mutations in tissue and liquid biopsies via a novel photoelectrochemical technology.From1 Jan 2023 → TodayFunding: FWO Humanitarian research project Stand up against Cancer
- Multiplexed photoelectrochemical detection technology for molecular cancer biomarkers (MultiSens).From1 Jan 2023 → 31 Dec 2023Funding: IOF - technology validation in lab
- A new photoelectrochemical singlet oxygen-based detection platform for a panel of cancer biomarkers in tissue and liquid biopsies (SOCAN).From1 Jan 2023 → TodayFunding: BOF - iBOF, University - Project driven research
- Improving diagnostic accuracy and follow-up of neuroendocrine neoplasms through detection of (epi)genetic biomarkers in liquid biopsies using novel technological platforms.From1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Investigation to reveal the immune reaction upon COVID vaccination in the Belgian cancer population: COVID protection and vaccine safety (REAL-V).From1 Oct 2022 → TodayFunding: Nonprofit institution or equivalents
- Towards informed decisions in colorectal cancer screening (ORIENT).From15 Aug 2022 → TodayFunding: Nonprofit institution or equivalents
- Center for Proteomics (CfP).From1 Jan 2022 → TodayFunding: BOF - research organisations
Publications
31 - 40 of 385
- Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma(2023)
Authors: E. Gabriela Chiorean, Vincent Picozzi, Chung-Pin Li, Marc Peeters, Joan Maurel, Jaswinder Singh, Talia Golan, Jean-Frederic Blanc, Sonya C. Chapman, Anwar M. Hussain, et al.
Pages: 20353 - 20364 - The immune microenvironment characterisation and dynamics in hormone receptor-positive breast cancer before and after neoadjuvant endocrine therapy(2023)
Authors: Gizem Öner, Christophe Van Berckelaer, Karen Zwaenepoel, Sevilay Altintas, Zafer Canturk, Wiebren Tjalma, Zwi Berneman, Marc Peeters, Patrick Pauwels, Peter Van Dam
Pages: 17901 - 17913 - Mucin-microbiome signatures shape the tumor microenvironment in gastric cancer(2023)
Authors: Baptiste Oosterlinck, Hannah Ceuleers, Wout Arras, Joris De Man, Karen Geboes, Heiko De Schepper, Marc Peeters, Sarah Lebeer, Jurgita Skieceviciene, Georgina L. Hold, et al.
Pages: 1 - 18 - Cellular senescence in cancer(2022)
Authors: Christophe Deben, Jasper Verswyvel, Tal Flieswasser, Hans Prenen, Marc Peeters, Filip Lardon, An Wouters
Pages: 1 - 35 - Co-targeting the EGFR and PI3K/Akt pathway to overcome therapeutic resistance in head and neck squamous cell carcinoma(2022)
Authors: Hannah Zaryouh, Jinthe Van Loenhout, Marc Peeters, Jan Vermorken, Filip Lardon, An Wouters
Pages: 1 - 10 - Pathophysiology and treatment of pancreatic neuroendocrine neoplasms (PNENS)(2022)
Authors: Laura Mariën, Odeta Islam, Laura Van Mileghem, Willem Lybaert, Marc Peeters, Timon Vandamme
Pages: 1 - 45 - Circulating DNA in the neoadjuvant setting of early stage colon cancer(2022)
Authors: Giacomo Bregni, Andrea Pretta, Chiara Senti, Elena Acedo Reina, Caroline Vandeputte, Elena Trevisi, Paraskevas Gkolfakis, Pashalina Kehagias, Amelie Deleporte, Jean-Luc Van Laethem, et al.
Pages: 1223 - 1229 - Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib(2022)
Authors: Ahmad Awada, Thierry Berghmans, Paul M. Clement, Kristof Cuppens, Bram De Wilde, Jean-Pascal Machiels, Patrick Pauwels, Marc Peeters, Sylvie Rottey, Eric Van Cutsem
- Differences and similarities in breast and colorectal cancer screening uptake among municipalities in Flanders, Belgium(2022)
Authors: Allegra Ferrari, Thuy Ngan Tran, Sarah Hoeck, Marc Peeters, Mathieu Goossens, Guido Van Hal
Pages: 84 - 96 - Systemic treatment of localized colorectal cancer(2022)
Authors: Hans Dedecker, Timon Vandamme, Laure-Anne Teuwen, Laura Wuyts, Hans Prenen, Albert Jan ten Tije, Marc Peeters
Pages: 257 - 271
Patents
1 - 6 of 6
- Combination immunotherapy of il-15 and cd40 agonist in cancer treatment (Inventor)
- Combination immunotherapy of IL-15 and CD40 agonist in cancer treatment (Inventor)
- Methylation detection assay (Inventor)
- Methylation status of gasdermin E gene as cancer biomarker (Inventor)
- Combination immunotherapy of IL-15 and CD40 agonist in cancer treatment (Inventor)
- Methylation status of gasdermin e gene as cancer biomarker (Inventor)